http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2016159204-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
filingDate | 2016-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2016159204-A1 |
titleOfInvention | A therapeutic composition comprising antithrombin gamma |
abstract | The present invention relates to a composition for the treatment of a thrombus formation tendency based on generalized intravascular coagulation syndrome or disseminated intravascular coagulation syndrome with concomitant antithrombin or congenital antithrombin deficiency, comprising antithrombin gamma. |
priorityDate | 2015-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.